Physician
Privia Medical Group Gulf Coast, PLLC
Privia Medical Group Gulf Coast, PLLC was paid $11.22M by Medicaid between Jan 2018 and Dec 2024, across 225 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoPRIVIA MEDICAL GROUP GULF COAST, PLLC
HOUSTON, TX 77054
HOUSTON, TX 77054
33aNPI1578969465assigned 11/05/2014
33bProvider typeNeurology Physician
28Total paid$11.22M
24GClaims676,980
24DCodes billed225
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Neurology Physician providers in Texas
Rank by total paid#1 of 122
Median peer was paid$15K
This provider vs. median747×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,116 | $11K | |
| 2019 | 4,022 | $38K | |
| 2020 | 22,963 | $466K | |
| 2021 | 136,965 | $2.62M | |
| 2022 | 199,337 | $3.17M | |
| 2023 | 198,453 | $3.01M | |
| 2024incomplete | 113,124 | $1.90M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 87,262 | 60,422 | $2.68M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 56,279 | 43,126 | $2.19M |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 10% | 2,159 | 2,041 | $1.16M |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2.7% | 3,265 | 2,953 | $303K |
| 59430 | 2.2% | 3,213 | 2,800 | $248K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.1% | 858 | 642 | $233K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.0% | 3,461 | 3,315 | $223K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.8% | 8,090 | 7,498 | $204K |
| 59514 | 1.8% | 320 | 299 | $198K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 3,074 | 2,719 | $197K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.7% | 8,037 | 7,444 | $195K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.7% | 1,050 | 299 | $190K |
213 more codes
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.6% | 3,453 | $179K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.3% | 6,327 | $146K |
| 99350 | Prolong home eval add 15m | 1.3% | 4,126 | $143K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 8,542 | $139K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1.2% | 115 | $132K |
| 99091 | 1.1% | 756 | $129K | |
| 81002 | 1.1% | 48,585 | $125K | |
| 99215 | Doctor's office visit, returning patient (complex) | 1.0% | 1,895 | $113K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,103 | $97K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,044 | $87K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,778 | $86K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 938 | $74K |
| 76830 | Ultrasound, transvaginal | <1% | 897 | $73K |
| 99310 | Prolong nursin fac eval 15m | <1% | 7,689 | $71K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 140 | $69K |
| 95813 | <1% | 253 | $66K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,115 | $63K |
| 76801 | <1% | 690 | $56K | |
| 81025 | <1% | 8,629 | $55K | |
| 99349 | <1% | 1,703 | $54K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 716 | $48K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 673 | $48K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 643 | $48K |
| 81514 | <1% | 619 | $45K | |
| 87481 | <1% | 2,401 | $44K | |
| 81513 | <1% | 1,026 | $42K | |
| 94375 | <1% | 1,791 | $41K | |
| 83970 | <1% | 1,710 | $39K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 3,262 | $36K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,559 | $36K |
| 80050 | General health panel | <1% | 1,208 | $34K |
| 87511 | <1% | 1,292 | $27K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,718 | $26K |
| 95117 | <1% | 3,223 | $24K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,476 | $24K |
| 96401 | <1% | 682 | $24K | |
| 99000 | <1% | 2,523 | $24K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 740 | $22K |
| 76818 | <1% | 271 | $22K | |
| 31231 | <1% | 190 | $21K | |
| 95913 | <1% | 118 | $19K | |
| 82607 | <1% | 2,167 | $18K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,576 | $18K |
| 59025 | Fetal non-stress test | <1% | 612 | $18K |
| 82746 | <1% | 2,044 | $17K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,574 | $15K |
| 20610 | <1% | 794 | $15K | |
| 92552 | <1% | 814 | $15K | |
| 84144 | <1% | 1,129 | $14K | |
| 95937 | <1% | 125 | $14K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 4,372 | $13K |
| 95886 | <1% | 126 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 955 | $13K |
| 73560 | <1% | 606 | $13K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 396 | $13K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,576 | $12K |
| 99205 | Prolong outpt/office vis | <1% | 127 | $12K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 167 | $11K |
| 99385 | <1% | 211 | $11K | |
| 73100 | <1% | 489 | $11K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 861 | $11K |
| 73120 | <1% | 508 | $10K | |
| 80061 | Lipid panel | <1% | 1,385 | $10K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 29 | $9K |
| 83735 | <1% | 1,968 | $9K | |
| 84146 | <1% | 784 | $9K | |
| 84439 | <1% | 1,954 | $9K | |
| 73620 | <1% | 459 | $8K | |
| 86304 | <1% | 782 | $8K | |
| 99050 | <1% | 536 | $7K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 341 | $7K |
| 84403 | <1% | 419 | $7K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 431 | $7K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 262 | $7K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 2,119 | $6K |
| 81000 | <1% | 2,145 | $6K | |
| 83550 | <1% | 1,507 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 551 | $6K |
| 82670 | <1% | 310 | $6K | |
| 20553 | <1% | 264 | $5K | |
| 95921 | <1% | 177 | $5K | |
| 83540 | <1% | 1,509 | $4K | |
| 80305 | <1% | 574 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,962 | $4K |
| 76998 | <1% | 37 | $4K | |
| 72040 | <1% | 161 | $4K | |
| 83001 | <1% | 309 | $4K | |
| 83002 | <1% | 310 | $4K | |
| 72100 | <1% | 144 | $4K | |
| 99051 | <1% | 329 | $3K | |
| 73110 | <1% | 185 | $3K | |
| 72170 | <1% | 195 | $3K | |
| 84479 | <1% | 1,131 | $3K | |
| 84436 | <1% | 1,074 | $3K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 42 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 520 | $3K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 119 | $3K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 392 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 144 | $3K |
| 73562 | <1% | 147 | $3K | |
| 73130 | <1% | 171 | $3K | |
| 72052 | <1% | 84 | $2K | |
| 58300 | <1% | 42 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 136 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 70 | $2K |
| 73630 | <1% | 132 | $2K | |
| 84702 | <1% | 200 | $2K | |
| 99381 | <1% | 27 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,686 | $2K |
| 90461 | <1% | 272 | $2K | |
| 84402 | <1% | 105 | $2K | |
| 93970 | <1% | 16 | $2K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 140 | $2K |
| 84270 | <1% | 121 | $2K | |
| 73030 | <1% | 96 | $1K | |
| 76813 | <1% | 19 | $1K | |
| 86328 | <1% | 32 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,317 | $1K |
| 11981 | <1% | 12 | $1K | |
| 84153 | <1% | 118 | $1K | |
| 99152 | <1% | 45 | $1K | |
| 84100 | <1% | 329 | $1K | |
| 99384 | <1% | 12 | $1K | |
| 72110 | <1% | 38 | $890.70 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 13 | $840.07 |
| 92250 | <1% | 16 | $776.25 | |
| 76814 | <1% | 16 | $767.64 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 538 | $693.77 |
| 72114 | <1% | 19 | $677.32 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 96 | $640.82 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $613.73 |
| 94729 | <1% | 12 | $525.36 | |
| 82947 | <1% | 185 | $524.99 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 208 | $492.60 |
| 90688 | <1% | 55 | $465.78 | |
| 76857 | <1% | 13 | $441.27 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 208 | $427.64 |
| 93925 | <1% | 17 | $398.28 | |
| 99490 | Ccm add 20min | <1% | 467 | $367.08 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 770 | $356.42 |
| 77080 | <1% | 13 | $326.37 | |
| 90686 | <1% | 169 | $300.36 | |
| 95251 | <1% | 14 | $277.37 | |
| 90661 | <1% | 14 | $261.00 | |
| 90658 | <1% | 15 | $225.68 | |
| 36410 | <1% | 15 | $165.83 | |
| 96161 | <1% | 471 | $139.98 | |
| 3044F | <1% | 1,641 | $124.86 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 89 | $104.70 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 39 | $103.14 |
| 99056 | <1% | 19 | $101.34 | |
| 82565 | <1% | 25 | $91.93 | |
| 96160 | <1% | 241 | $72.22 | |
| 93922 | <1% | 14 | $65.22 | |
| 84481 | <1% | 20 | $35.70 | |
| 90694 | <1% | 16 | $26.50 | |
| 3046F | <1% | 22 | $20.00 | |
| 99072 | <1% | 18 | $15.00 | |
| 99499 | <1% | 1,744 | $3.94 | |
| 3074F | 0% | 39,624 | $0.00 | |
| 3008F | 0% | 51,743 | $0.00 | |
| 3079F | 0% | 9,127 | $0.00 | |
| 3075F | 0% | 4,963 | $0.00 | |
| 1036F | 0% | 45,655 | $0.00 | |
| 1126F | 0% | 7,925 | $0.00 | |
| 1125F | 0% | 1,627 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 294 | $0.00 |
| 90651 | 0% | 38 | $0.00 | |
| 1034F | 0% | 2,464 | $0.00 | |
| 96127 | 0% | 3,410 | $0.00 | |
| 3080F | 0% | 2,669 | $0.00 | |
| 81099 | 0% | 800 | $0.00 | |
| 1101F | 0% | 2,232 | $0.00 | |
| S0612 | Annual gynecological examination, established patient | 0% | 13 | $0.00 |
| 99024 | 0% | 132 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,717 | $0.00 |
| 1035F | 0% | 778 | $0.00 | |
| 1170F | 0% | 150 | $0.00 | |
| 99459 | 0% | 636 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 179 | $0.00 |
| 90680 | 0% | 61 | $0.00 | |
| 90723 | 0% | 40 | $0.00 | |
| 90698 | 0% | 62 | $0.00 | |
| 36416 | 0% | 46 | $0.00 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 17 | $0.00 |
| 99457 | 0% | 16 | $0.00 | |
| 1111F | 0% | 17 | $0.00 | |
| 2023F | 0% | 14 | $0.00 | |
| 99439 | 0% | 16 | $0.00 | |
| Q4206 | Fluid flow or fluid gf, 1 cc | 0% | 23 | $0.00 |
| 90744 | 0% | 17 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 13 | $0.00 |
| 99458 | 0% | 16 | $0.00 | |
| 3725F | 0% | 6,668 | $0.00 | |
| 1160F | 0% | 38,089 | $0.00 | |
| 3077F | 0% | 3,059 | $0.00 | |
| 1159F | 0% | 35,453 | $0.00 | |
| 3078F | 0% | 35,219 | $0.00 | |
| 3288F | 0% | 2,638 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 297 | $0.00 |
| 99497 | 0% | 145 | $0.00 | |
| 1100F | 0% | 154 | $0.00 | |
| 0502F | 0% | 146 | $0.00 | |
| 90756 | 0% | 247 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 40 | $0.00 |
| 90648 | 0% | 44 | $0.00 | |
| 90670 | 0% | 128 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 435 | $0.00 |
| 99173 | 0% | 460 | $0.00 | |
| 90734 | 0% | 30 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 24 | $0.00 |
| 90633 | 0% | 15 | $0.00 | |
| 1090F | 0% | 66 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJORDAN, BARBARA (AVP REVENUE CYCLE MANAGEMENT)
| Provider | Location | Paid |
|---|---|---|
| East Aurora Pediatrics | East Aurora, NY | $395K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.